Franco Rovelli

2.7k total citations
123 papers, 2.1k citations indexed

About

Franco Rovelli is a scholar working on Endocrine and Autonomic Systems, Oncology and Immunology. According to data from OpenAlex, Franco Rovelli has authored 123 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrine and Autonomic Systems, 29 papers in Oncology and 24 papers in Immunology. Recurrent topics in Franco Rovelli's work include Circadian rhythm and melatonin (38 papers), Cancer, Stress, Anesthesia, and Immune Response (18 papers) and Immune Cell Function and Interaction (16 papers). Franco Rovelli is often cited by papers focused on Circadian rhythm and melatonin (38 papers), Cancer, Stress, Anesthesia, and Immune Response (18 papers) and Immune Cell Function and Interaction (16 papers). Franco Rovelli collaborates with scholars based in Italy, Switzerland and United States. Franco Rovelli's co-authors include Paolo Lissoni, Gabriele Tancini, Sandro Barni, F Brivio, Fernando Brivio, Fabio Malugani, Luca Fumagalli, A. Conti, Luca Fumagalli and Georges J. M. Maestroni and has published in prestigious journals such as PEDIATRICS, Cancer and British Journal of Cancer.

In The Last Decade

Franco Rovelli

120 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franco Rovelli Italy 25 715 469 369 362 269 123 2.1k
Carole Rovère France 32 501 0.7× 397 0.8× 352 1.0× 816 2.3× 425 1.6× 63 2.8k
Nobuya Ogawa Japan 29 290 0.4× 351 0.7× 109 0.3× 536 1.5× 254 0.9× 157 2.5k
F Brivio Italy 22 393 0.5× 435 0.9× 283 0.8× 235 0.6× 220 0.8× 61 1.3k
Melanie D. Klok Netherlands 12 487 0.7× 158 0.3× 190 0.5× 544 1.5× 492 1.8× 12 2.1k
Mary Ann Wilson United States 29 200 0.3× 124 0.3× 222 0.6× 872 2.4× 198 0.7× 60 3.2k
Bunpei Ishizuka Japan 23 367 0.5× 168 0.4× 156 0.4× 641 1.8× 139 0.5× 89 2.4k
Xia Liu China 24 272 0.4× 106 0.2× 184 0.5× 692 1.9× 268 1.0× 61 1.9k
Jennifer Gallagher United Kingdom 13 629 0.9× 379 0.8× 254 0.7× 1.7k 4.8× 917 3.4× 24 3.6k
María Pascual Spain 38 181 0.3× 266 0.6× 463 1.3× 1.4k 3.7× 591 2.2× 86 4.9k

Countries citing papers authored by Franco Rovelli

Since Specialization
Citations

This map shows the geographic impact of Franco Rovelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Rovelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Rovelli more than expected).

Fields of papers citing papers by Franco Rovelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Rovelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Rovelli. The network helps show where Franco Rovelli may publish in the future.

Co-authorship network of co-authors of Franco Rovelli

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Rovelli. A scholar is included among the top collaborators of Franco Rovelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Rovelli. Franco Rovelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lissoni, Paolo, et al.. (2020). COVID-19 Disease as an Acute Angiotensin 1-7 Deficiency: A Preliminary Phase 2 Study with Angiotensin 1-7 in Association with Melatonin and Cannabidiol in Symptomatic COVID19 -Infected Subjects. 3(2). 1 indexed citations
3.
4.
5.
Lissoni, Paolo, et al.. (2010). HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.. PubMed. 23(6). 987–9. 3 indexed citations
6.
Lissoni, Paolo, et al.. (2009). A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.. PubMed. 23(1). 171–5. 47 indexed citations
7.
Lissoni, Paolo, Gabriele Fumagalli, Fernando Brivio, et al.. (2004). Endocrine Effects of Erythropoietin in Cancer Patients. Hematology. 9(5-6). 363–367. 2 indexed citations
8.
Lissoni, Paolo, R Bucovec, Luisa Giani, et al.. (2001). Thrombopoietic properties of 5‐methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer‐related thrombocytopenia. Journal of Pineal Research. 30(2). 123–126. 20 indexed citations
9.
Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1998). Immunobiological effects of interleukin-2, interleukin-12 or interleukin-2 plus interleukin-12 in metastatic cancer patients. 14(1). 41–44. 1 indexed citations
10.
11.
Antoniucci, David, et al.. (1997). Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente.. PubMed. 27(4). 363–9. 14 indexed citations
12.
Cazzaniga, Marina Elena, et al.. (1995). Prediction of Recurrence in Operable Breast Cancer by Postoperative Changes in Prolactin Secretion. Oncology. 52(6). 439–442. 14 indexed citations
13.
Lissoni, Paolo, Sandro Barni, Gabriele Tancini, et al.. (1994). A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. British Journal of Cancer. 69(1). 196–199. 79 indexed citations
14.
Lissoni, Paolo, Sandro Barni, Franco Rovelli, et al.. (1993). Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results. European Journal of Cancer. 29(2). 185–189. 34 indexed citations
15.
Brivio, F, E. Tisi, Franco Rovelli, et al.. (1993). In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2. Cancer. 71(6). 2076–2081. 21 indexed citations
16.
Lissoni, Paolo, Sandro Barni, Gabriele Tancini, et al.. (1993). Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract. British Journal of Cancer. 67(6). 1404–1407. 47 indexed citations
17.
Lissoni, Paolo, E. Tisi, Sandro Barni, et al.. (1992). Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer. British Journal of Cancer. 66(1). 155–158. 32 indexed citations
18.
Lissoni, Paolo, Sandro Barni, R Rescaldani, Franco Rovelli, & Gabriele Tancini. (1989). Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours. British Journal of Cancer. 60(4). 616–617. 9 indexed citations
19.
Lissoni, Paolo, Antonio Bastone, R Mauri, et al.. (1987). The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels. European Journal of Cancer and Clinical Oncology. 23(7). 949–957. 23 indexed citations
20.
Barni, Sandro, Paolo Lissoni, Franco Paolorossi, et al.. (1987). Effects of radical mastectomy on prolactin blood levels in patients with breast cancer. European Journal of Cancer and Clinical Oncology. 23(8). 1141–1145. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Rovère Breakdown of academic impact, for papers by Nobuya Ogawa Breakdown of academic impact, for papers by F Brivio Breakdown of academic impact, for papers by Melanie D. Klok Breakdown of academic impact, for papers by Mary Ann Wilson Breakdown of academic impact, for papers by Bunpei Ishizuka Breakdown of academic impact, for papers by Xia Liu Breakdown of academic impact, for papers by Jennifer Gallagher Breakdown of academic impact, for papers by María Pascual
Rankless by CCL
2026